- Nestle just announce it has bought Pamlab, a Louisiana-based food company that makes vitamin rich supplements that help battle depression.
- This is the second medical food company that Nestle has bought in the past eight months under its subsidiary, Nestle Health Sciences.
- NHS is focusing on prescription based nutritional therapy, an industry it believes will see excellent growth in the years to come.
From the article:
The undisclosed buy follows Nestlé Health Science’s (NHS) July 2012 investment in Accera, the US firm behind Axona, another pharma-food (phood) targeted at people with mild to moderate Alzheimer’s.
Nestlé spokesperson Hilary Green told us Pamlab will not be integrated with Accera, that it would, "continue to
operate as a stand-alone business within the Nestlé Health Science company, and its organisational structure won’t change."